SCHEMBL21273016

SCHEMBL21273016

Clc1ncnc2c1cc(Br)n2-c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.48
ALDH1A1 P00352 3/20 0.48
HTT P42858 3/20 0.48
GAA P10253 2/20 0.48
OPRD1 P41143 1/20 0.48
OPRK1 P41145 1/20 0.48
PAX8 Q06710 1/20 0.48
TLR9 Q9NR96 1/20 0.48
SRC P12931 1/20 0.41
PDE4A P27815 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4C Q08493 1/20 0.40
PDE4D Q08499 1/20 0.40
PI4KA P42356 3/20 0.36
PI4K2B Q8TCG2 3/20 0.36
PI4K2A Q9BTU6 3/20 0.36
PI4KB Q9UBF8 3/20 0.36
EGFR P00533 2/20 0.36
MEN1 O00255 4/20 0.35
KMT2A Q03164 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17154070 0.81 MAPT (0.48) MAPTALDH1A1HTTGAAOPRD1
SCHEMBL5560155 0.75 ADORA2A (0.35) MAPTALDH1A1HTTGAAOPRD1
SCHEMBL21273198 0.75 USP7 (0.42) MAPTALDH1A1HTTGAAOPRD1
SCHEMBL5564252 0.73 SRC (0.41) ALDH1A1HTTGAASRCPDE4A
SCHEMBL30440833 0.73 SRC (0.41) ALDH1A1HTTGAASRCPDE4A
SCHEMBL21273095 0.70 ALDH1A1 (0.50) MAPTALDH1A1GAASRCPDE4A
SCHEMBL20351707 0.69 SRC (0.51) MAPTALDH1A1HTTGAAOPRD1
SCHEMBL2077026 0.68 ALDH1A1 (0.67) MAPTALDH1A1HTTGAAPI4KA
SCHEMBL30034914 0.68 ALDH1A1 (0.67) MAPTALDH1A1HTTGAAPI4KA
SCHEMBL5763739 0.68 MEN1 (0.52) ALDH1A1HTTMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4026832-A1 PIPERIDINE DERIVATIVES AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7 Almac Discovery Limited (GB) 2022-07-13 EP disclosed
US-10766903-B2 Piperidine derivatives as inhibitors of ubiquitin specific protease 7 ALMAC DISCOVERY LIMITED (GB) 2020-09-08 US disclosed
US-20190256518-A1 PIPERIDINE DERIVATIVES AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7 GENETECH, INC. 2019-08-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190256518-A1 PIPERIDINE DERIVATIVES AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7 USP7, USP5, UBA7 MAPT 1438/4885ALDH1A1 1201/4885HTT 1374/4885
US-10766903-B2 Piperidine derivatives as inhibitors of ubiquitin specific protease 7 USP7, USP5, UBA7 MAPT 1438/4885ALDH1A1 1201/4885HTT 1374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.